Survival analyses further supported PRPH's prognostic value, showing that ALS patients with higher baseline PRPH levels had longer survival times, as evidenced by the graphs concerning both the time elapsed between onset and death/tracheostomy and that between sampling and death/tracheostomy. Here, PRPH is linked to amyotrophic lateral sclerosis.